MENU

RSQCX Royce Small-Cap Special Equity Consult Forecast, Technical & Fundamental Analysis

The investment seeks long-term growth of capital... Show more

Category: #Small Value
Interact to see
Advertisement
A.I.Advisor
published Highlights

Industry description

The investment seeks long-term growth of capital. The fund's investment adviser invests the fund's assets primarily in equity securities of small-cap companies. The fund invests at least 80% of its net assets in equity securities of small-cap companies, under normal circumstances. Although the fund normally focuses on securities of U.S. companies, it may invest up to 10% of its net assets (measured at the time of investment) in securities of companies headquartered in foreign countries.

Market Cap

The average market capitalization across the Royce Small-Cap Special Equity Consult MF is 2.14B. The market cap for tickers in the group ranges from 519.88M to 7.97B. VSH holds the highest valuation in this group at 7.97B. The lowest valued company is EBF at 519.88M.

Volume

The average weekly volume growth across all stocks in the Royce Small-Cap Special Equity Consult MF was 55%. For the same stocks of the MF, the average monthly volume growth was 268% and the average quarterly volume growth was 346%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 49
P/E Growth Rating: 41
Price Growth Rating: 47
SMR Rating: 100
Profit Risk Rating: 63
Seasonality Score: 34 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category SmallValue

Profile
Details
Category
Small Value
Address
Royce Fund745 Fifth AvenueNew York
Phone
(212) 508-4546
Web
www.roycefunds.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBOE290.6010.28
+3.67%
Cboe Global Markets
DOUG1.720.01
+0.58%
Douglas Elliman
CPRX31.330.05
+0.18%
Catalyst Pharmaceuticals
ESPR3.14-0.01
-0.32%
Esperion Therapeutics
INTS3.71-0.07
-1.85%
Intensity Therapeutics Inc.

RSQCX and MutualFunds

Correlation & Price change

A.I.dvisor indicates that over the last year, RSQCX has been closely correlated with ASVRX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if RSQCX jumps, then ASVRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSQCX
1D Price
Change %
RSQCX100%
+0.86%
ASVRX - RSQCX
88%
Closely correlated
+1.13%
SSGSX - RSQCX
76%
Closely correlated
N/A
DFSVX - RSQCX
74%
Closely correlated
N/A
DFFVX - RSQCX
74%
Closely correlated
N/A
VSCAX - RSQCX
72%
Closely correlated
N/A
More
Royce Small-Cap Special Equity Consult (RSQCX) mutual fund Forecast, Price Targets and Analysts Predictions - Tickeron.com